Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA126505-05
Application #
8112543
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
2012-01-01
Budget Start
2010-09-01
Budget End
2012-01-01
Support Year
5
Fiscal Year
2010
Total Cost
$82,745
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Seeley, Erin H; Wilson, Kevin J; Yankeelov, Thomas E et al. (2014) Co-registration of multi-modality imaging allows for comprehensive analysis of tumor-induced bone disease. Bone 61:208-16
Johnson, Rachelle W; Merkel, Alyssa R; Page, Jonathan M et al. (2014) Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer. Clin Exp Metastasis 31:945-59
Pickup, Michael W; Laklai, Hanane; Acerbi, Irene et al. (2013) Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-?-deficient mouse mammary carcinomas. Cancer Res 73:5336-46
Jin, Renjie; Sterling, Julie A; Edwards, James R et al. (2013) Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone. PLoS One 8:e60983
Thiolloy, Sophie; Edwards, James R; Fingleton, Barbara et al. (2012) An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment. PLoS One 7:e29862
Basanta, D; Scott, J G; Fishman, M N et al. (2012) Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game. Br J Cancer 106:174-81
Li, Xiaohong; Sterling, Julie A; Fan, Kang-Hsien et al. (2012) Loss of TGF-? responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Mol Cancer Res 10:494-503
Novitskiy, Sergey V; Pickup, Michael W; Chytil, Anna et al. (2012) Deletion of TGF-? signaling in myeloid cells enhances their anti-tumorigenic properties. J Leukoc Biol 92:641-51
Basanta, David; Gatenby, Robert A; Anderson, Alexander R A (2012) Exploiting evolution to treat drug resistance: combination therapy and the double bind. Mol Pharm 9:914-21
Anderson, Philip D; McKissic, Sydika A; Logan, Monica et al. (2012) Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. J Clin Invest 122:1907-19

Showing the most recent 10 out of 48 publications